Responses

Download PDFPDF

Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer
Free
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    The Cutting Edge
    • Calvin S.H. Ng, Cardiothoracic Surgeon
    • Other Contributors:
      • Song Wan, Ahmed Arifi, Anthony Yim

    Dear Editor

    “A good surgeon knows how to operate. A better surgeon knows when to operate. The best surgeon knows when not to operate.”

    Clinical Surgery in General 3rd Edition Royal College of Surgeons of England Course Manual

    We found the article "Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer" by Janssen- Heijnen et al [1] very interesti...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Re: Does co-morbidity not influence histological confirmation?

    Dear Editor

    We agree with Anderson that age and significant co-morbidity might reduce the chances of getting histology. In the population of our study the proportion of patients with a clinical diagnosis was 7%. This proportion varied from almost 3% for patients younger than 65 to 8% for those aged 65-79 and 22% for those aged 80 or older. In patients younger than 65 or in those aged 80 or older this proportio...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Does co-morbidity not influence histological confirmation?

    Dear Editor

    I read the article by Janssen-Heijnen et al with interest [1]. There are large differences in the reported survival of patients presenting with lung cancer. Those presenting in the United states and Spain are reported to have up to twice the chance of surviving five years when compared to those presenting in the United Kingdom [2-4]. This may be due to differences in disease, differences in performanc...

    Show More
    Conflict of Interest:
    None declared.